srhypedt a2ad2
Name
a2a2
Label
Angiotensin Type 2 Antagonists (SHHS2)
Description

Participant taking ANGIOTENSIN TYPE 2 ANTAGONISTS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
A2A2
Angiotensin Type 2 Antagonists (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No - 3,444 -
Yes - 176 -
Unknown 5,804 460 5,042
Angiotensin Type 2 Antagonists (SHHS2) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No - - - - -
Yes - - - - -
Unknown 1,451 1,451 1,451 1,451 5,804
Angiotensin Type 2 Antagonists (SHHS2) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No - - -
Yes - - -
Unknown 3,039 2,765 5,804
Angiotensin Type 2 Antagonists (SHHS2) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No 1,857 1,587 3,444
Yes 102 74 176
Unknown 260 200 460
Angiotensin Type 2 Antagonists (SHHS2) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No - - - - - - -
Yes - - - - - - -
Unknown 4,907 515 11 88 280 3 5,804
Angiotensin Type 2 Antagonists (SHHS2) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No 3,008 232 5 37 161 1 3,444
Yes 154 10 1 6 5 - 176
Unknown 425 14 2 5 14 - 460